Pfizer’s Hospira Site in India Lands Another FDA Form 483

Pfizer’s Hospira Site in India Lands Another FDA Form 483

Submitted by admin on July 13, 2018 - 11:23pm
Source: 
RAPS.org
News Tags: 
FDA
Pfizer
Hospira
drug manufacturing
Headline: 
Pfizer’s Hospira Site in India Lands Another FDA Form 483
snippet: 

In a 32-page US Food and Drug Administration (FDA) Form 483, 11 citations revealed manufacturing and quality control issues at the Hospira Healthcare India facility in Tamil Nadu.

Do Not Allow Advertisers to Use My Personal information